SHANGHAI / JINGMEN – On April 9, 2026, EVE Energy unveiled its groundbreaking CR123AP medical-grade battery at the 93rd China International Medical Equipment Fair (CMEF) Spring Edition. Designed specifically for life-critical healthcare applications, the new cell combines industry-leading performance with sustainable manufacturing, addressing the most pressing pain points of modern medical device development.
With over 20 years of specialized expertise in medical battery technology, EVE Energy has built a comprehensive ecosystem powering implantable devices, in-vitro diagnostics, emergency equipment, and surgical tools. As automated external defibrillators (AEDs) become ubiquitous in public spaces and electric surgical staplers demand ever-higher performance, the industry faces increasingly strict requirements for battery reliability, extreme-environment resilience, and environmental sustainability. EVE Energy’s CR123AP was engineered from the ground up to meet these evolving demands, redefining benchmarks for medical battery performance.
Four Core Advantages Redefining Medical Battery Performance
The CR123AP directly overcomes the limitations of traditional medical batteries, delivering four transformative advantages that ensure stable, reliable operation for life-critical equipment:
Ultra-Long Cycle Life: Powered by proprietary high-pulse output technology, the CR123AP offers cycle life far exceeding industry averages, dramatically reducing replacement frequency and lowering total ownership costs for medical device manufacturers and healthcare providers.
Superior Rate Capability: A stable, consistent high-rate pulse platform enables precise, instantaneous safety activation, meeting the rigorous operational demands of emergency and surgical equipment where even millisecond delays can have life-altering consequences.
Industry-Leading Low-Temperature Performance: At -20°C, the CR123AP delivers pulse output capability 5.92 times higher than competing products, eliminating cold-environment usage limitations for AEDs and portable medical devices deployed in harsh climates.
Sustainable Green Manufacturing: Produced using EVE Energy’s innovative dry electrode process, the battery achieves a low-carbon footprint across its entire lifecycle, aligning with global healthcare industry sustainability goals without compromising performance.
Proprietary Dry Electrode Technology Drives Breakthrough Performance
The CR123AP’s exceptional performance stems directly from EVE Energy’s proprietary dry electrode manufacturing process. Unlike conventional solvent-based slurry methods, this innovative approach eliminates hazardous solvents, simplifies production workflows, and significantly reduces carbon emissions. It also enhances the electrode’s conductive architecture and mechanical stability, resulting in superior pulse output strength, low-temperature adaptability, and long-term operational reliability—all critical for meeting the strictest international medical device safety standards.
EVE Energy continues to advance its medical battery technology roadmap, with ongoing efforts to optimize self-discharge characteristics, extend effective service life, and broaden temperature-range adaptability. Additionally, AI-powered intelligent inspection and fully digitalized manufacturing ensure that every single CR123AP cell maintains exceptional consistency, safety, and dependability—non-negotiable requirements for life-supporting and emergency medical equipment.
Global Dual-Base Production Ensures Reliable Worldwide Supply
From project initiation in 2025 to full mass production in 2026, the CR123AP medical battery will be manufactured simultaneously at EVE Energy’s dual production bases in Jingmen, China and Penang, Malaysia. This global production footprint enables the company to deliver consistent, high-quality products to medical customers worldwide, with reduced lead times and enhanced supply chain resilience.
As EVE Energy deepens its roots in the medical battery sector, it remains committed to its core philosophy: “A battery is a living entity — we treat every cell with reverence.” By combining relentless technological innovation with sustainable manufacturing practices, EVE Energy is empowering the next generation of medical device upgrades, safeguarding global health, and enabling a better, more sustainable future for all.
Welcome to contact us:
Inquiry more product details from the : Lithium Ion Battery Manufacturers
WhatsApp/Wechat/Mobile: +86 13332949210
Email: info@xihobattery.com
Website: www.xihobattery.com
EVE Energy Showcases Energy Solutions at 2026 World UAV Expo
240 pcs of CATL 3.2V 104Ah LiFePo4 batteries to Australia
Sodium Ion Battery: The Emerging Energy Storage Solution for Global ESS & EV Projects
